These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Engulfing action of glial cells is required for programmed axon pruning during Drosophila metamorphosis. Awasaki T; Ito K Curr Biol; 2004 Apr; 14(8):668-77. PubMed ID: 15084281 [TBL] [Abstract][Full Text] [Related]
29. Degeneration of Injured Axons and Dendrites Requires Restraint of a Protective JNK Signaling Pathway by the Transmembrane Protein Raw. Hao Y; Waller TJ; Nye DM; Li J; Zhang Y; Hume RI; Rolls MM; Collins CA J Neurosci; 2019 Oct; 39(43):8457-8470. PubMed ID: 31492772 [TBL] [Abstract][Full Text] [Related]
30. Regulation of degenerative spheroids after injury. Yong Y; Gamage K; Cushman C; Spano A; Deppmann C Sci Rep; 2020 Sep; 10(1):15472. PubMed ID: 32963272 [TBL] [Abstract][Full Text] [Related]
31. Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo. Milde S; Gilley J; Coleman MP Bioarchitecture; 2013; 3(5):133-40. PubMed ID: 24284888 [TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms in the initiation phase of Wallerian degeneration. Chang B; Quan Q; Lu S; Wang Y; Peng J Eur J Neurosci; 2016 Aug; 44(4):2040-8. PubMed ID: 27062141 [TBL] [Abstract][Full Text] [Related]
34. Axon death signalling in Wallerian degeneration among species and in disease. Llobet Rosell A; Neukomm LJ Open Biol; 2019 Aug; 9(8):190118. PubMed ID: 31455157 [TBL] [Abstract][Full Text] [Related]
35. Deep Learning to Decipher the Progression and Morphology of Axonal Degeneration. Palumbo A; Grüning P; Landt SK; Heckmann LE; Bartram L; Pabst A; Flory C; Ikhsan M; Pietsch S; Schulz R; Kren C; Koop N; Boltze J; Madany Mamlouk A; Zille M Cells; 2021 Sep; 10(10):. PubMed ID: 34685519 [TBL] [Abstract][Full Text] [Related]
36. Distinct pathways mediate axon degeneration during apoptosis and axon-specific pruning. Cusack CL; Swahari V; Hampton Henley W; Michael Ramsey J; Deshmukh M Nat Commun; 2013; 4():1876. PubMed ID: 23695670 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic opportunities and pitfalls in the treatment of axon degeneration. Simon DJ; Watkins TA Curr Opin Neurol; 2018 Dec; 31(6):693-701. PubMed ID: 30320612 [TBL] [Abstract][Full Text] [Related]
38. Involvement of lysosomes in the early stages of axon degeneration. Zheng J; Yan T; Feng Y; Zhai Q Neurochem Int; 2010 Feb; 56(3):516-21. PubMed ID: 20036294 [TBL] [Abstract][Full Text] [Related]
39. cADPR is a gene dosage-sensitive biomarker of SARM1 activity in healthy, compromised, and degenerating axons. Sasaki Y; Engber TM; Hughes RO; Figley MD; Wu T; Bosanac T; Devraj R; Milbrandt J; Krauss R; DiAntonio A Exp Neurol; 2020 Jul; 329():113252. PubMed ID: 32087251 [TBL] [Abstract][Full Text] [Related]